Peer Review History

Original SubmissionNovember 28, 2024
Decision Letter - Vijayaprasad Gopichandran, Editor

Dear Dr. Mancini,

Please submit your revised manuscript by Aug 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Vijayaprasad Gopichandran

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

Kindly pay close attention to the two reviewers' comments and revise accordingly.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

Reviewer #1: This is a very interesting paper tackling a relevant research area. The methodology used is very appropriate for addressing the intended objectives. The discussions and conclusions were aligned to the results. Ethics approval was sought, and participants had the opportunity to provide consent for participation in line with ethics requirements.

Reviewer #2: Lines 90 & 91, and lines 108-109 – The first objective of the study reads “to assess whether providing brief information on CTs improved the general impression of and willingness to participate in CTs in a sample of socioeconomically disadvantaged” whereas the exclusion criteria say “persons who reported that they had never heard of CTs in the survey questionnaire were 108 secondarily excluded from the analysis.” If people were not provided information, how are they expected to participate irrespective of the method of information? Please explain why this was given as an exclusion factor

Line 100, page 4 – Please provide brief information on what is meant by the IPSOS i-Say sampling panel

Lines 144-149, page 5 – The authors mention 3 groups, but there is no explanation on why there are 3 groups in the study, and what the 3 groups are. Please provide the rationale

Lines 145-147, page 5 – There is no explanation on why a tabular form was chosen for the information regarding CTs. What was the rationale behind choosing the tabular formats?

Lines 145-147, page 5 – Why are there two tabular formats, and why was it pooled later during the analysis?

Lines 160-162, page 6 – Why was group 1 excluded from the analysis? Please provide an explanation

Table 1, page 7 – While the study objective is to see whether there is an improved willingness to participate in CT and the general impression about the CTs, is there a baseline captured on similar information? Without a baseline, how could the comparison be done to say whether such a method of information would improve the participation in CT?

Lines 46-47, page 1 – the Discussion/Conclusion section of the abstract that “The initial impression of CTs was quite poor in this socioeconomically disadvantaged sample, but improved after the brief information note on CTs was provided”. Where is the corresponding data for this? Any baseline assessment percentages and comparison with the post test?

Lines 95-98, page 4 – How did the participant selection happen? Was there any particular method of sampling used to select the participants?

Lines 312-314, page 12 – “In our study, providing individuals with brief pertinent information helped to improve their general impression of CTs and, to some extent, their willingness to participate in them” – does it corresponds to the tabular form or textual form?

Reviewer #3: The study documents the effect of presenting information about clinical trials in different formats (textual vs tabular) on the perceptions and hypothetical willingness of socioeconomically disadvantaged individuals in France to participate in such trials. The research is relevant and timely, addressing an important gap in health communication and equity in clinical trial participation.

Comment 1:

The use of the term “participation” in the title might be misleading, as actual clinical trial participation was not measured. Consider revising the title to reflect the assessment of hypothetical willingness, such as:

“Providing brief information on clinical trials in appropriate formats may improve impressions and willingness to participate among socioeconomically disadvantaged people in France.”

Comment 2:

Please consider adding a brief introduction of the definition of clinical trial for a broader audience.

Comment 3:

On Page 3, line 61, the percentage value “28.0%” is duplicated. Please correct this typographical error.

Comment 4:

The repeated use of the phrase “many studies” in the introduction contributes to a monotonous tone. Rephrase it for improved readability.

Comment 5:

On Page 4, line 89, consider rephrasing the sentence “focused specifically on the second information step listed above” to directly state the study’s objectives.

Comment 6:

Provide a brief description of the IPSOS i-Say panel, including the total number invited, response rate, participant incentives, and how representative the sample is of socioeconomically disadvantaged individuals in France.

Comment 7:

The sentence “Included persons who reported that they had never heard of CTs… were secondarily excluded from the analysis” can be moved from the methodology to the Results section to improve logical flow. The term “secondary exclusion criterion” can be removed.

Comment 8:

Briefly describe the validity of the tools used (e.g., SILS, SNS3, table comprehension score) and their appropriateness for the target population.

Comment 9:

Clarify whether the information notes were delivered via the same online platform as the survey.

Comment 10:

Please confirm whether data were collected anonymously and describe the measures taken to ensure data security and confidentiality.

Comment 11:

On Page 7, line 185, there appears to be a discrepancy regarding the proportion of participants with chronic conditions. Table 1 lists 35%, while the text mentions 37%. Please ensure consistency between tables and text.

Comment 12:

On Page 8, line 200, replace vague fractions such as “three-quarters” with exact proportions or percentages and revise throughout the manuscript (e.g., “two-fifths,” “four-fifths”).

Comment 13:

On Page 10, line 236, please verify and correct any inconsistencies between the regression coefficients mentioned in the text and those reported in Table S2

Comment 14: Consider elaborating more explicitly on potential biases in your study, such as selection bias, social desirability bias, and response bias, particularly given the online, self-reported nature of the survey.

Comment 15:

Reference 10 should be translated and formatted as:

Schultz, É., Ward, J.K., Touzani, R., Rouquette, A. and Mancini, J. (2024). Between Health and Science: Health Literacy and the Perception of Medical Research. Santé Publique, 36(3), 103–108. https://doi.org/10.3917/spub.243.0103

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  RAJESWARAN THIAGESAN

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PLOS_CT Information Sheet & Consent_Reviewer Comments.docx
Revision 1

Responses to reviewers

To the editor

Dear editor, thank you for your interest in our submission. We have read the reviewers' comments with great interest and have responded point by point to each of them. We have also modified the manuscript wherever necessary to improve the paper for possible publication in your illustrious journal.

Review Comments to the Author

Reviewer #1

This is a very interesting paper tackling a relevant research area. The methodology used is very appropriate for addressing the intended objectives. The discussions and conclusions were aligned to the results. Ethics approval was sought, and participants had the opportunity to provide consent for participation in line with ethics requirements.

Resp : Thank you very much for your comment.

Reviewer #2

Lines 90 & 91, and lines 108-109 – The first objective of the study reads “to assess whether providing brief information on CTs improved the general impression of and willingness to participate in CTs in a sample of socioeconomically disadvantaged” whereas the exclusion criteria say “persons who reported that they had never heard of CTs in the survey questionnaire were 108 secondarily excluded from the analysis.” If people were not provided information, how are they expected to participate irrespective of the method of information? Please explain why this was given as an exclusion factor

Resp : Thank you for your comment, which may help to clarify things. Indeed, the aim of the study was to find out whether providing information about clinical trials (CTs) would improve their impression and willingness to participate. This assumes that those taking part in this analysis have already heard of clinical trials as the question about baseline (cf. infra) impression (and willingness to participate) was only asked to people who already have heard of them. This is why it seemed logical to us to exclude people who have never heard of CTs, as in the pilot study of the questionnaire it was reported that it makes no sense to ask people about their general impression about CTs if they had responded just before that they have never heard of CTs. This is why the questions were filtered and why it was not possible to include those participants in the analysis.

To simplify reading, as suggested by Reviewer #3, we have removed this exclusion criterion from the method section, and left the information relating to the exclusion of these participants in the results section.

Line 100, page 4 – Please provide brief information on what is meant by the IPSOS i-Say sampling panel

Resp : IPSOS i-Say is an online access panel of volunteers recruited by Ipsos (an international research company). Participants in Ipsos iSay surveys earn points and redeem them for gift cards.

Lines 144-149, page 5 – The authors mention 3 groups, but there is no explanation on why there are 3 groups in the study, and what the 3 groups are. Please provide the rationale

Resp : Thank you for your comment. The main hypothesis of our work was that “providing information would improve the impression of CTs” and secondly that the form of this information could have a different impact depending on people's characteristics. The idea behind this is to see whether this information should be adapted to the population studied in order to improve the chance of having good results; this is why 3 groups were randomly constituted to test three different forms of information. In group 1 the information was in the form of a simple text talking about the CTs, and in groups 2 and 3 (renamed 2a and 2b) the information was in the form of a brief comparative table with 4 questions and answers. We initially developed an information table with six questions and answers, but it was not possible to include all six questions at once, as the text would have been significantly longer compared to the text provided to group 1. This is why we formed two subgroups, each with two common and two different questions, including specific information about the potential risks and burden of CT participation in group 2b. We have provided further details in the manuscript as follows and added a translation of the brief information in an Appendix.

"In order to study whether the form of information could have an impact on the impression and willingness to participate in CTs, we provided information in three forms (corresponding to three groups): In group 1 the information given was completely text-based talking about the CTs, and in groups 2a and 2b the information was in the form of a comparative table with 4 questions and answers about CTs."

Lines 145-147, page 5 – There is no explanation on why a tabular form was chosen for the information regarding CTs. What was the rationale behind choosing the tabular formats?

Resp : As mentioned above, the rationale behind this choice lies in the fact that we hypothesized that those who are comfortable with the structure of a table would better understand and be more at ease with this type of information. Asking and answering a question would push them to reason a little, and the fact that it was in a comparative tabular form would enable them to stratify and better organize the information. This format was inspired by options grids developed by Elwyn et al. [1].

Lines 145-147, page 5 – Why are there two tabular formats, and why was it pooled later during the analysis?

Resp : Some people's impression of a subject is often heavily influenced by what they know about the risks associated with it. We made two tabular forms to emphasize the questions about risk that some people in group 2b might have asked themselves. In the end, for this manuscript, we decided to compare only the “textual” form and the “tabular” form, regardless of content; this is why we pooled groups 2a and 2b.

Lines 160-162, page 6 – Why was group 1 excluded from the analysis? Please provide an explanation

Resp : Group 1 was not excluded from the analyses. Groups 2a and 2b were pooled, and in the end the statistical analysis was based on two groups: group 1 and groups 2 (group 2a and 2b pooled. To remove any ambiguity, we have added a sentence to clarify matters.

« In the remainder of the manuscript, we will therefore refer to two groups: the textual information group (group 1) and the tabular information group (group 2: group 2a and group 2b pooled). »

Table 1, page 7 – While the study objective is to see whether there is an improved willingness to participate in CT and the general impression about the CTs, is there a baseline captured on similar information? Without a baseline, how could the comparison be done to say whether such a method of information would improve the participation in CT?

Resp : Thank you for your comment. In Table 1, page 8, we have the baseline data (before providing the brief information on the CTs) with the median for impression and willingness to participate. In Table 2, we have the same information after the provision of the material, and the statistical tests carried out show us that there has been an improvement. Since we're talking about a “feeling”, the reference base for a participant is himself, because we want to know whether his impression of the CTs and his willingness to take part have improved. For willingness to participate, we have been more nuanced, specifying in certain places (Line 188, for example) that it is more a question of “hypothetical willingness” to take part in a CT. We have added the term ‘baseline’ in the text and Table 1 to clarify.

Lines 46-47, page 1 – the Discussion/Conclusion section of the abstract that “The initial impression of CTs was quite poor in this socioeconomically disadvantaged sample, but improved after the brief information note on CTs was provided”. Where is the corresponding data for this? Any baseline assessment percentages and comparison with the post test?

Resp : The corresponding data can be found in Tables 1 and 2, and in Figure 1, which clearly shows a pre-post information evolution.

Lines 95-98, page 4 – How did the participant selection happen? Was there any particular method of sampling used to select the participants?

Resp : As stated in the manuscript, sampling was carried out by IPSOS i-say access panel. The participants already registered in this commercial online panel were selected on a voluntary basis if they matched the inclusion criteria.

Lines 312-314, page 12 – “In our study, providing individuals with brief pertinent information helped to improve their general impression of CTs and, to some extent, their willingness to participate in them” – does it corresponds to the tabular form or textual form?

Resp : As shown in Figures 1 and S1, and specified in the manuscript (lines 214-215), the impression of CTs and willingness to participate improved across the entire population, regardless of the form of information received.

Reviewer #3

The study documents the effect of presenting information about clinical trials in different formats (textual vs tabular) on the perceptions and hypothetical willingness of socioeconomically disadvantaged individuals in France to participate in such trials. The research is relevant and timely, addressing an important gap in health communication and equity in clinical trial participation.

Comment 1: The use of the term “participation” in the title might be misleading, as actual clinical trial participation was not measured. Consider revising the title to reflect the assessment of hypothetical willingness, such as:

“Providing brief information on clinical trials in appropriate formats may improve impressions and willingness to participate among socioeconomically disadvantaged people in France.”

Resp: Thank you for your suggestion. The title of the manuscript has been changed according to your recommendations.

Comment 2: Please consider adding a brief introduction of the definition of clinical trial for a broader audience.

Resp: Thank you for your comment. We have provided a brief definition of clinical trials for the reader.

« Clinical trials Clinical trials (CTs) are research studies in which patients volunteer to help test new ways to treat, diagnose, or prevent diseases. They are used to determine if a new test or treatment works and is [2]. »

Comment 3: On Page 3, line 61, the percentage value “28.0%” is duplicated. Please correct this typographical error.

Resp: Thank you, it's done!

Comment 4:

The repeated use of the phrase “many studies” in the introduction contributes to a monotonous tone. Rephrase it for improved readability.

Resp: Thank you, it's done!

Comment 5: On Page 4, line 89, consider rephrasing the sentence “focused specifically on the second information step listed above” to directly state the study’s objectives.

Resp: Thank you for your comment. We have rewritten according to your recommendations.

Comment 6: Provide a brief description of the IPSOS i-Say panel, including the total number invited, response rate, participant incentives, and how representative the sample is of socioeconomically disadvantaged individuals in France.

Resp: IPSOS i-Say is an online access panel of millions of volunteers worldwide recruited by Ipsos (an international research company). Participants in Ipsos iSay surveys earn points and redeem them for gift cards. The survey was proposed to all members corresponding to the inclusion criteria and was closed as soon as 400 panelists responded. We were not able to ascertain how many panelists received our survey invitation and therefore not able to calculate a response rate. The panel is not perfectly representative of socioeconomically disadvantaged individuals in France as it is based on volunteers able to respond online surveys. However, Ipsos applies rigorous processes (including ongoing monitoring and renewal) to ensure the source of panelists is representative of the general population (including a mix of offline and online recruitment).

Comment 7: The sentence “Included persons who reported that they had never heard of CTs… were secondarily excluded from the analysis” can be moved from the methodology to the Results section to improve logical flow. The term “secondary exclusion criterion” can be removed.

Resp: Thank you for your comment. We have removed this sentence from the method and left it in the results as it was already there.

Comment 8: Briefly describe the validity of the tools used (e.g., SILS, SNS3, table comprehension score) and their appropriateness for the target population.

Resp: Once again, thank you for the relevance of your comment. We have tried to establish the validity of the different scales or scores used in this population, as follows. In addition, we have chosen these short, validated scales were used to maximize the probability of obtaining responses in these disadvantaged populations.

« SILS : SILS has proven its ability to predict functional autonomy assessed using other self-reported measures [3]. SILS is a valid tool for some rapidly identifying people with limited functional health literacy [4].

SNS3 : A validation study has shown that the SNS-3 is sufficiently reliable and valid to be used as a measure of subjective numeracy [5].

Table comprehension score: This score which is simply the sum of the scores obtained for three questions asked, has not been psychometrically validated and was designed ad-hoc for the a previous US stud [6].

Comment 9: Clarify whether the information notes were delivered via the same online platform as the survey.

Resp: After completing the baseline online questionnaire, participants were provided via the same online platform a brief information note which explained the objectives and procedures of CTs

Comment 10: Please confirm whether data were collected anonymously and describe the measures taken to ensure data security and confidentiality.

Resp: The data were collected anonymously. To ensure data security and confidentiality, an anonymous database without IP address or any potentially identifying information was transferred by IPSOS to the research group.

Comment 11: On Page 7, line 185, there appears to be a discrepancy regarding the proportion of participants with chronic conditions. Table 1 lists 35%, while the text mentions 37%. Please ensure consistency between tables and text.

Resp: Thanks for this comment, the data between the text and the table have been harmonized.

Comment 12: On Page 8, line 200, replace vague fractions such as “three-quarters” with exact proportions or percentages and revise throughout the manuscript (e.g., “two-fifths,” “four-fifths”).

Resp: Thank you, it's done!

Comment 13: On Page 10, line 236, please verify and correct any inconsistencies between the regression coefficients mentioned in the text and those reported in Table S2

Resp: Thank you, it's done!

Comment 14: Consider elaborating more explicitly on potential biases in your study, such as selection bias, social desirability bias, and response bias, particularly given the online, self-reported nature of the survey.

Resp: In line with your recommendations, we have added a sentence to the study limits.

« This study has limitations arising from the survey method used. First, the study sample may not fully represent the most disadvantaged people in France because of our recruitment process (i.e., using a sampling panel) and potential non-responses of some eligible participants. Second, we had no control group with higher incomes in our study. Studies on the general population are needed in order to compare our results. Finally, we cannot exclude social desirability bias with potential more positive impressions reported after reading the information note. »

Comment 15: Reference 10 should be translated and formatted as:

Schultz, É., Ward, J.K., Touzani, R., Rouquette, A. and Mancini, J. (2024). Between Health and Science: Health Literacy and the Perception of Medical Research. Santé Publique, 36(3), 103–108. https://doi.org/10.3917/spub.243.0103

Resp: Thank you, it's done!

References

1. Elwyn G, Lloyd A, Joseph-Williams N, Cording E, Thomson R, Durand MA, et al. Option Grids: shared decision making made easier. Patient Educ Couns. févr 2013;90(2):207‑12.

2. Mancini J, Briggs A, Elkin EB, Regan J, Hickey C, Targett C, et al.

Attachments
Attachment
Submitted filename: Response_to_Reviewers.docx
Decision Letter - Vijayaprasad Gopichandran, Editor

Providing brief information on clinical trials in appropriate formats may improve impressions and willingness to participate among socioeconomically disadvantaged people in France.

PONE-D-24-54157R1

Dear Dr. Mancini,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vijayaprasad Gopichandran

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Well revised.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Vijayaprasad Gopichandran, Editor

PONE-D-24-54157R1

PLOS ONE

Dear Dr. Mancini,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vijayaprasad Gopichandran

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .